Manuel Ferrara Prostate

Docetaxel and Estramustine Compared with Mitoxantrone and

Mitoxantrone-based chemotherapy palliates pain without extending survival in men with progressive androgen-independent cancer.

The reactive stroma microenvironment and cancer

N 1993 Inhibition of vascular endothelial growth factor-induced and Webber, Jason, 2024, "Integration of proteomic and metabolomic

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for

The potential role of bisphosphonates in cancer. Cancer Prostatic Dis 2002;5:264-272 Conson,; Roberto Pacelli,. Metastasis

Insights into the Human Microbiome and Its Connections with

A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates cancer progression. O., Biggs

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for

Mitoxantrone plus prednisone reduces pain and improves the quality of life in men with advanced, hormone-refractory cancer,

Response Prediction of 177Lu-PSMA-617 Radioligand Therapy

Röhrich, Klaus Kopka, Markus membrane antigen expression as a predictor of cancer progression.

Transforming Growth Factor-β1 (TGF-β)–induced Apoptosis of

Herein, we report that apoptosis of human cancer PC-3U cells induced by TGF-β1 or Smad7 overexpression is caused by a specific activation of the p38

Response Prediction of 177Lu-PSMA-617 Radioligand Therapy

Methods: One hun- dred consecutive patients with metastasized castration-resistant cancer scheduled for PSMA RLT were evaluated for

Christopher J. Logothetis | MD Anderson Cancer Center

Cancer Prostatic Dis 26(4):751-758, 2023. e-Pub 2022. PMID F, Staquicini DI, Driessen WH, D'Angelo S, Dobroff AS, Barry M, Lomo LC

The role of vitamin D receptor gene polymorphisms in the

risk for cancer, cancer onset after the age of 66 years, name of Rui de Medeiros Melo Silva. We acknowledge Drs. Carlos Torres